Racial/ethnic and regional differences in the prevalence of inflammatory bowel disease in the United States

Digestion

Volumn 88, Issue 1, 2013, Pages 20-25

  Wang, Yize R ^a,b   Loftus, Edward V ^c   Cangemi, John R ^a   Picco, Michael F ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Crohn's disease; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

ADULT; ARTICLE; ASIAN; BLACK PERSON; CAUCASIAN; CONTROLLED STUDY; CROHN DISEASE; ETHNIC DIFFERENCE; FEMALE; HEALTH SURVEY; HISPANIC; HOUSEHOLD; HUMAN; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MINORITY GROUP; NORTH AMERICA; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; SOUTH AMERICA; ULCERATIVE COLITIS; UNITED STATES;

ADULT; COLITIS, ULCERATIVE; CONTINENTAL POPULATION GROUPS; CROHN DISEASE; ETHNIC GROUPS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; UNITED STATES;

EID: 84879142411     PISSN: 00122823     EISSN: 14219867     Source Type: Journal    
DOI: 10.1159/000350759     Document Type: Article

References (37)

1. Loftus EV Jr: Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004: 126: 1504-1517.
2. Loftus EV Jr, Silverstein MD, Sandborn, et al: Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology 1998; 114: 1161-1168.
3. Loftus EV Jr, Silverstein MD, Sandborn WJ, et al: Ulcerative colitis in Olmsted Country, Minnesota, 1940-1993: incidence, prevalence, and survival. Gut 2000; 46: 336-343.
4. Loftus CG, Loftus EV Jr, Harmsen WS, et al: Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted Country, Minnesota, 1940-2000. Inflamm Bowel Dis 2007; 13: 254-261.
5. Kappelman MD, Rifas-Shiman SL, Kleinman K, et al: The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol 2007; 5: 1424-1429.
6. Loftus EV Jr: The burden of inflammatory bowel disease in the United States: a moving target? Clin Gastroenterol Hepatol 2007; 5: 1383-1384.
7. Herrinton LJ, Liu L, Lafata JE, et al: Estimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensings. Inflamm Bowel Dis 2007; 13: 451-461.
8. Herrinton LJ, Liu L, Lewis JD, et al: Incidence and prevalence of inflammatory bowel disease in a Northern California managed care organization, 1996-2002. Am J Gastroenterol 2008; 103: 1998-2006.
9. Kurata JH, Kantor-Fish S, Frankl H, et al: Crohn's disease among ethnic groups in a large health maintenance organization. Gastroenterology 1992; 102: 1940-1948.
10. Pinchbeck BR, Kirdeikis J, Thomson AB: Inflammatory bowel disease in northern Alberta. An epidemiologic study. J Clin Gastroenterol 1988; 10: 505-515.
11. Bernstein CN, Blanchard JF, Rawsthorne P, et al: Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol 1999: 149: 916-924.
12. Straus WL, Eisen GM, Sandler RS, et al: Crohn's disease: does race matter The Mid-Atlantic Crohn's Disease Study Group. Am J Gastroenterol 2000; 95: 479-483.
13. Lee YM, Fock K, See SJ, et al: Racial differences in the prevalence of ulcerative colitis and Crohn's disease in Singapore. J Gastroenterol Hepatol 2000; 15: 622-625.
14. Sood A, Midha V, Sood N, et al: Incidence and prevalence of ulcerative colitis in Punjab, North India. Gut 2003; 52: 1587-1590.
15. Reddy SI, Burakoff R: Inflammatory bowel disease in African Americans. Inflamm Bowel Dis 2003; 9: 380-385.
16. Basu D, Lopez L, Kulkarni A, et al: Impact of race and ethnicity on inflammatory bowel disease. Am J Gastroenterol 2005; 100: 2254-2261.
17. Cross RK, Jung C, Wasan S, et al: Racial differences in disease phenotypes in patients with Crohn's disease. Inflamm Bowel Dis 2006; 12: 192-198.
18. Hilmi I, Tan YM, Goh KL: Crohn's disease in adults: observations in a multiracial Asian population. World J Gastroenterol 2006; 12: 1435-1438.
19. Nguyen GC, Torres EA, Regueiro M, et al: Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanics whites: characterization of a large North American cohort. Am J Gastroenterol 2006; 101: 1012-1023.
20. Fujimoto T, Kato J, Kuriyama M, et al: Change of clinical characteristics of ulcerative colitis in Japan: analysis of 844 hospital-based patients from 1981 to 2000. Eur J Gastroenterol Hepatol 2007; 19: 229-235.
21. Mahid SS, Mulhall AM, Gholson RD, et al: Inflammatory bowel disease and African Americans: a systematic review. Inflamm Bowel Dis 2008; 14: 960-967.
22. Chow DK, Leong RW, Tsoi KK, et al: Longterm follow-up of ulcerative colitis in the Chinese population. Am J Gastroenterol 2009; 104: 647-654.
23. Hou JK, El-Serag H, Thirumurthi S: Distribution and manifestations of inflammatory bowel disease in Asians, Hispanics, and African Americans: a systemic review. Am J Gastroenterol 2009; 104: 2100-2109.
24. Zheng JJ, Zhu XS, Huangfu Z, et al: Prevalence and incidence rates of Crohn's disease in mainland China: a meta-analysis of 55 years of research. J Dig Dis 2010; 11: 161-166.
25. Sonnenberg A, McCarty DJ, Jacobsen SJ: Geographic variation of inflammatory bowel disease within the United States. Gastroenterology 1991; 100: 143-149.
26. Sewell JL, Yee HF, Inadomi JM: Hospitalizations are increasing among minority patients with Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 2010; 16: 204-207.
27. Sullivan PW, Morrato EH, Ghushchyan V, et al: Obesity, inactivity, and the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the U.S., 2000-2002. Diabetes Care 2005; 28: 1599-1603.
28. Machlin S, Cohen J, Elixhauser A, et al: Sensitivity of household reported medical conditions in the Medical Expenditure Panel Survey. Med Care 2009; 47: 618-625.
29. Johnson AE, Sanchez ME: Household and medical reports on medical conditions: National Medical Expenditure Survey. J Econ Soc Meas 1993; 19: 199-223.
30. Edwards WS, Win DM, Kurlantzick V, et al: Evaluation of National Health Interview Survey diagnostic reporting. National Center for Health Statistics, Vital Health 1994; 2: 120.
31. Hendriksen C, Kreiner S, Binder V: Long term prognosis in ulcerative colitis-based on results from a regional patient group from the county of Copenhagen. Gut 1985; 26: 158-163.
32. Bamias G, Nyce MR, De La Rue SA, et al: New concepts in the pathophysiology of inflammatory bowel disease. Ann Intern Med 2005; 143: 895-904.
33. Dassopoulos T, Nguyen GC, Talor MV, et al: NOD2 mutations and anti-Saccharomyces cerevisiae antibodies are risk factors for Crohn's disease in African Americans. Am J Gastroenterol 2010; 105: 378-386.
34. Leong RW, Armuzzi A, Ahmad T, et al: NOD/CARD15 gene polymorphisms and Crohn's disease in the Chinese population. Aliment Pharmacol Ther 2003; 17: 1465-1470.
35. Li M, Gao X, Guo CC, et al: OCTN and CARD15 gene polymorphism in Chinese patients with inflammatory bowel disease. World J Gastroenterol 2008; 14: 4923-4927.
36. Gent AE, Hellier MD, Grace RH, et al: Inflammatory bowel disease and domestic hygiene in infancy. Lancet 1994; 343: 766-767.
37. Green C, Elliott L, Beaudoin C, et al: A population-based ecologic study of inflammatory bowel disease: searching for etiologic clues. Am J Epidemiol 2006; 164: 615-623.